[ad_1]
A ClearPoint Neuro’s medical device plays an important role in UniQure’s effort to battle Huntington’s disease.
[ad_2]
Source link
Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it
Related Posts
John Goodman’s historic New Orleans home finds a buyer after he lowered price to $4.75 million
[ad_1] Hollywood legend John Goodman has found a buyer for his beloved New Orleans home, six months after he put the historic property on the…
Is the economy as good as Wall Street says it is? Financial markets and the data are telling different stories.
[ad_1] Strong second-quarter earnings have been led by financial and tech firms, but they’ve offered little evidence of robust consumer…
Lilly obesity-pill trial results find a warmer reception on Wall Street this time around
[ad_1] Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron. [ad_2] Source…